Methods: Between January 2015 and January 2022, a total of 17 neonates (12 males, 5 females; median age: 14 days, range, 5 to 34 days) who underwent carotid artery surgical cut-down technique for ductal stenting were retrospectively analyzed. Diagnoses of the patients, demographics, procedural success/failure, access-related complications, and neuroimaging findings were recorded.
Results: The primary indication for ductal stenting was pulmonary atresia in all patients. All patients who underwent carotid cut-down had vertical anatomy, with or without tortuous ductal anatomy, and they were not suitable for the femoral approach. The median body weight was 3 (range, 2 to 3.4) kg. Fifteen of the 17 interventions (88.2%) were successful. Two patients whose stenting failed underwent a systemic-to-pulmonary shunt operation. The early in-hospital mortality rate was 17.6% (n=3). No neurological or accessrelated complications were observed in any of the patients.
Conclusion: Stenting the ductus arteriosus with challenging anatomy is feasible and safe with carotid artery cut-down, particularly in small neonates. Based on our study findings, this technique may offer an effective and less invasive alternative to the systemic-to-pulmonary shunt operation.
Access to the vertical ductus and advancement of the stent via the retrograde route may be difficult due to the acute angle of the ductus originating from the aortic arch. Longer procedure time and smaller vessel diameter due to the low body weight also increase the risk of vascular complications. In such patients, the only alternative to the SPS operation may be to use an alternative access for ductal stenting, such as the axillary or carotid artery, which provides a more direct route. Therefore, the popularity of alternative routes has been increasing.[6-11] However, there is no consensus on the preferred route (axillary or carotid) or access technique (percutaneous or surgical cut-down). Some authors prefer the percutaneous technique, which requires some compression to be applied after removing the catheter to control bleeding. The risk of cerebral or arm ischemia is the drawback of this approach due to the high risk of thrombosis, hematoma, or pseudoaneurysm formation.[10-12] Our technique of choice is carotid artery cut-down. Carotid arteries are easy to manipulate even in neonates due to the larger diameter than the femoral artery. Moreover, access is quick and easy, with a small neck incision, given the superficial location. Then, repairing the vessel hole with a simple fine stitch after catheter removal, to avoid the risk of compression-related complications, is safe and feasible.
In the present study, we aimed to evaluate early and mid-term outcomes of ductal stenting via carotid artery cut-down technique.
Procedure
To provide a better placement of a ductal
stent, prostaglandin E1 infusion was stopped
24 h before catheter intervention with close clinical
follow-up. However, in patients who did not tolerate
discontinuation of prostaglandin E1, prostaglandin E1
infusion was resumed, until the wire traversed into the
ductus. All procedures were performed under general
anesthesia and orotracheal intubation. Procedures
were carried out with full cardiac monitorization.
Preoperative transthoracic echocardiography (TTE)
was used to determine the ductal anatomy and select
which carotid artery would be used. Patients received
intravenous 100 U/kg of heparin immediately before
sheath placement, and we kept the activated clotting
time (ACT) over 200 sec. The side arm of the sheath
was connected to a transducer with saline with 1 U
heparin per mL. The carotid artery was prepared with
a small oblique neck incision. The needle puncture
side in the anterior wall of the common carotid artery
was secured with a "U" stitch with a 7-0 prolene
suture. Carotid artery cannulation was performed using the semi-Seldinger technique with the 4F sheath
in all cases (Figure 1). After completing the procedure,
the purse suture was tied to close the puncture site.
Vascular clamping was not used in any part of the
procedure, including sheath withdrawal and primary
repair. Cefazolin prophylaxis was received for 24 h.
The ductus was screened with the left lateral view and right or left anterior oblique angle. All ductus arteriosus (DA) had a vertical and/or tortuous morphology, and we measured the ductal length after the wire traversing to gain a more accurate measurement. All patient's DA narrowest part at the pulmonary side was smaller than 3 mm. Therefore, we selected a stent larger than 3 mm and decided on the size according to the children's body weight. In patients weighing less than 3 kg, we decided on a 3.5-mm-diameter stent; in patients weighing 3 to 4 kg, we chose a 4-mm-diameter stent. The stent length was extended 1 to 2 mm more than the ductal length. All patients received a 5 mg/kg dose of acetylsalicylic acid starting 4 h from successful stenting, and heparin infusion was stopped 24 h after the procedure.
The patients were followed in the pediatric cardiac intensive care unit (ICU). Stent patency and cardiac evaluation were carried out by clinical examination, oxygen saturation (SpO2) level, chest X-ray, and echocardiography immediately after the procedure, on the first day after the procedure, before discharge and, if re-evaluation was needed. Seven days after discharge, all patients were scheduled for re-examination with a chest X-ray and echocardiography. All patients were followed monthly after the first control, until reintervention or surgery. The need for reintervention or surgery was determined based on the patient's growth, SpO2 l evel, a nd c ardiac p athology. C ardiac catheterization or computed tomography (CT) scan was used for screening before surgery. Early mortality was defined as death before discharge or death within one month from surgery.
S tent m igration o ccurred i n o ne p atient a nd unsuccessful stent deployment in another. Both patients whose ductal stenting failed underwent SPS surgery, and one died during hospital stay (Table 2).
Table 1. Diagnoses of patients
Table 2. Demographic and clinical characteristics of patients
Early mortality
Early mortality occurred in three patients (17.6%).
One patient who was diagnosed with right atrial
isomerism and pulmonary atresia died the day after
SPS surgery due to unsuccessful ductal stenting.
Another patient was diagnosed with right atrial
isomerism and pulmonary atresia and underwent
two successful ductal interventions. The first was
performed via the femoral vein to the right DA,
and the second was completed two days after initial
stenting to the left DA via the carotid approach. This patient died two months after the procedure due to
septic complications. The remaining patient diagnosed
with tricuspid atresia with pulmonary atresia had
pulmonary overflow and died despite ductal closure
and an SPS operation one week later. All other patients
had an uneventful post-procedural recovery with early
extubation, indicating that they had a shorter ICU and
hospital stay.
Follow-up
Five patients died during follow-up. Two of them
who were diagnosed with right atrial isomerism
and pulmonary atresia died at home after discharge
(after one and 29 months). The patient who died
29 months after stenting was lost to follow-up; the
date of death was found in the national death database.
Other three patients died after second-stage surgery.
The Rastelli operation was successfully performed in four patients and the Glenn procedure in four patients. Of the latter two patients, both had successful Fontan completion after the Glenn procedure, and one underwent unifocalization and right ventricle-to-pulmonary artery conduit implantation.
No neurological complications were observed in any of the patients due to ductal stenting. Transfontanellar ultrasound (US) examinations were performed on a regular basis in all patients. Carotid Doppler US showed the patency of all carotid arteries. In five patients, the carotid arteries were screened with CT angiography, additional with pulmonary artery imaging, and all carotid arteries were normal. In seven patients, the carotid arteries were screened during preoperative invasive angiography before total correction and for a second- and/or third-stage procedure, and all patients had normal carotid arteries. Details of the interventions and outcomes are given in Table 3. Figure 2a illustrates a three-dimensional CT screening, and Figure 2b illustrates a conventional angiography screening before a second-stage operation.
Table 3. Details of the interventions and outcomes
In the present study, we primarily investigated access-related complications and the feasibility and safety of ductal stenting via carotid artery cut-down for neonates. Currently, the percutaneous approach has become widespread to reduce surgeon dependency and vascular injury.[9] Yet, the carotid approach offers advantages as an alternative to SPS surgery or in case of an unsuccessful attempt, particularly in small neonates and patients with challenging ductal anatomy such as vertical and tortuous DA. In contrast to recent studies of the percutaneous approach, in our literature review of the percutaneous approach,[15-17] we found no vascular access-related complications such as hematoma, surgical re-exploration, or pseudoaneurysm. The authors usually reported mild or no stenosis in a small proportion of their patients. Similar to these reports, we observed no such complications. However, Breatnach et al.[8] reported access-related complications in three of 20 (15%) (n=2 partial dissections and n=1 pseudoaneurysm) using the percutaneous axillary artery approach. Choudhry et al.[12] reported pseudoaneurysms in 2 of 18 (11.1%) patients using the percutaneous carotid approach. Furthermore, Polat[9] reported complications in seven of 30 patients who underwent cardiac catheterization via the percutaneous carotid approach. Five complications (n=2 non-occlusive thrombi, n=1 mild luminal carotid narrowing, and n=2 hematomas) did not require surgical intervention, but two (n=1 pseudoaneurysm and n=1 hematoma that jeopardized the upper airway tract) were treated surgically. Satisfactory results may be gained with an experienced surgical team back-up. We never clamped or snared the carotid arteries in ductal stenting. All procedures were performed using a 4-Fr sheath, and "U"-shaped purse-string sutures were placed just a needle width apart. This is the so-called semi-Seldinger technique, which has been used particularly in extracorporeal membrane oxygenation (ECMO) applications and peripheral cannulation requiring cardiac surgery for many years.[18,19] The main idea of this technique is to use the Seldinger method after surgical exploration of the vessel. The decision on whether to use classic "U"-shaped sutures or double-pledgeted horizontal "U" sutures[19] is at the surgeon's discretion based on their experience.
Controversy surrounds the percutaneous approach in adult cardiovascular diseases. For many years, surgical femoral exposure has been used to access the femoral artery in the non-surgical treatment of aortic aneurysms and transaortic valve implantation. Currently, adult cardiac teams mostly use Perclose ProGlide? and ProStar? XL (Abbott Vascular, CA, USA) to reduce percutaneous access-related complications. Still, many articles report the superiority of surgical exposure.[20,21] Furthermore, some authors have proposed that surgical femoral exposure is cost-effective and safer than percutaneous access with closure devices. [20] In this regard, ductal stenting may be more hazardous than adult percutaneous procedures, since vascular-related complications are more difficult to handle in neonates and infants than in adults. In addition, the market does not provide suitable-sized closure devices for pediatrics. Despite all of this, manual compression after sheath decannulation in percutaneous carotid procedures does not seem to be safe. While inadequate compression may lead to bleeding, hematoma, and pseudoaneurysm, too much compression of the carotid artery may lead to carotid artery thrombosis and reduced cerebral flow. Our carotid artery approach with minimal surgical exploration and no vessel clamping, similar to that of Cakici et al.,[22] seems to be safer than percutaneous intervention.
The other alternative approach, instead of using the femoral artery for cardiac intervention, is to use the axillary artery. The main reason to prefer the axillary over the carotid approach is to avoid cerebral injury. Meanwhile, studies have reported that carotid artery access does not reduce cerebral perfusion significantly. Lahiri et al.[23] reported that cerebral perfusion does not change significantly during cardiac catheterization via the carotid artery or after sheath removal. Additionally, they reported that no patient had a documented neurologic deficit following the procedure. Buesing et al.[24] examined that carotid artery ligation did not increase cerebral injury or neurodevelopmental impairment in ECMO survival patients who underwent the procedure via a carotid artery. Since neonates and infants have excellent collateralization, performing procedures via a carotid artery, even in larger ECMO cannula and carotid artery ligation, does not alter the neurological outcomes significantly. Similar to these reports, cerebral injury has not been documented for any of our participants in roughly four years of follow-up. Also, the axillary artery approach with blind arterial access may cause vascular complications such as hematoma, pseudoaneurysm, and dissection.[24]
The main limitation to this study is its single-center, retrospective design. Although this study has a large patient group, further multi-center, large-scale, prospective studies are needed to draw more reliable conclusions on this subject.
In conclusion, in small neonates with challenging ductal anatomy, ductal stenting with carotid access should be kept in mind. Surgical-assisted carotid artery approach may offer a safe and feasible alternative to percutaneous approaches. The risks of access-related complications are low. Further comparative studies are needed to decide the most optimal approach for these challenging patients.
Acknowledgments: Special thanks to cardiovascular intensive care nurse Ebru Arlı for the drawing.
Ethics Committee Approval: The study protocol was approved by the Acıbadem University Ethics Committee (date: 25.02.2022, no: 2022-04/11). The study was conducted in accordance with the principles of the Declaration of Helsinki.
Patient Consent for Publication: A written informed consent was obtained from the parents and/or legal guardians of the patients.
Data Sharing Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.
Author Contributions: Idea/concept, design: S.B., S.A., E.E.; Control/supervision: E.O., E.E.; Data collection and/or processing: S.B., A.O., B.T.; Analysis and/or interpretation: S.B., F.G.; Literature review: S.B., B.T., A.C.; Writing the article: S.B., E.O., E.E.; Critical review: E.O., E.E.; References and fundings: A.O., B.T.; Materials: S.B., E.E.
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Funding: The authors received no financial support for the research and/or authorship of this article.
1) Coe JY, Olley PM. A novel method to maintain ductus
arteriosus patency. J Am Coll Cardiol 1991;18:837-41. doi:
10) 1016/0735-1097(91)90810-v.
2) Gibbs JL, Rothman MT, Rees MR, Parsons JM, Blackburn
ME, Ruiz CE. Stenting of the arterial duct: A new approach
to palliation for pulmonary atresia. Br Heart J 1992;67:240-5.
doi: 10.1136/hrt.67.3.240.
3) Onalan MA, Odemis E, Saygi M, Temur B, Aydin S,
Demir IH, et al. Early and midterm results of ductal stent
implantation in neonates with ductal-dependent pulmonary
circulation: A single-centre experience. Cardiol Young
2020;30:1772-82. doi: 10.1017/S104795112000267X.
4) Ratnayaka K, Nageotte SJ, Moore JW, Guyon PW, Bhandari
K, Weber RL, et al. Patent ductus arteriosus stenting for all
ductal-dependent cyanotic infants: Waning use of Blalock-
Taussig shunts. Circ Cardiovasc Interv 2021;14:e009520. doi:10.1161/CIRCINTERVENTIONS.120.009520.
5) Glatz AC, Petit CJ, Goldstein BH, Kelleman MS,
McCracken CE, McDonnell A, et al. Comparison
between patent ductus arteriosus stent and modified
Blalock-Taussig shunt as palliation for infants with
ductal-dependent pulmonary blood flow: Insights from
the congenital catheterization research collaborative.
Circulation 2018;137:589-601. doi: 10.1161/
CIRCULATIONAHA.117.029987.
6) Ligon RA, Kim DW, Vincent RN, Bauser-Heaton HD, Ooi
YK, Petit CJ. Angiographic follow-up of infants and children
undergoing percutaneous carotid artery interventions.
Catheter Cardiovasc Interv 2018;91:1301-6. doi: 10.1002/
ccd.27481.
7) Justino H, Petit CJ. Percutaneous common carotid artery
access for pediatric interventional cardiac catheterization.
Circ Cardiovasc Interv 2016;9:e003003. doi: 10.1161/
CIRCINTERVENTIONS.115.003003.
8) Breatnach CR, Aggarwal V, Al-Alawi K, McMahon CJ,
Franklin O, Prendiville T, et al. Percutaneous axillary
artery approach for ductal stenting in critical right
ventricular outflow tract lesions in the neonatal period.
Catheter Cardiovasc Interv 2019;93:1329-35. doi: 10.1002/
ccd.28302.
9) Polat TB. Stenting the vertical ductus arteriosus via axillary
artery access using "wire-target" technique. Congenit Heart
Dis 2017;12:800-7. doi: 10.1111/chd.12512.
10) Bauser-Heaton H, Qureshi AM, Goldstein BH, Glatz AC,
Nicholson GT, Meadows JJ, et al. Use of carotid and axillary
artery approach for stenting the patent ductus arteriosus in
infants with ductal-dependent pulmonary blood flow: A
multicenter study from the congenital catheterization research
collaborative. Catheter Cardiovasc Interv 2020;95:726-33.
doi: 10.1002/ccd.28631.
11) Polat TB. Use of percutaneous carotid artery access for
performing pediatric cardiac interventions: Single-center
study. Ann Pediatr Cardiol 2020;13:16-24. doi: 10.4103/apc.
APC_26_19.
12) Choudhry S, Balzer D, Murphy J, Nicolas R, Shahanavaz S.
Percutaneous carotid artery access in infants < 3 months of
age. Catheter Cardiovasc Interv 2016;87:757-61. doi: 10.1002/
ccd.26310.
13) Azzolina G, Eufrate SA, Allella A. New approach to
catheterization of the heart in infants and children. Br Heart
J 1973;35:643-6. doi: 10.1136/hrt.35.6.643.
14) Davenport JJ, Lam L, Whalen-Glass R, Nykanen DG, Burke
RP, Hannan R, et al. The successful use of alternative routes
of vascular access for performing pediatric interventional
cardiac catheterization. Catheter Cardiovasc Interv
2008;72:392-8. doi: 10.1002/ccd.21621.
15) Weber HS, Mart CR, Kupferschmid J, Myers JL, Cyran
SE. Transcarotid balloon valvuloplasty with continuous
transesophageal echocardiographic guidance for neonatal
critical aortic valve stenosis: An alternative to surgical
palliation. Pediatr Cardiol 1998;19:212-7. doi: 10.1007/
s002469900287.
16) Borghi A, Agnoletti G, Poggiani C. Surgical cutdown of
the right carotid artery for aortic balloon valvuloplasty in
infancy: Midterm follow-up. Pediatr Cardiol 2001;22:194-7.
doi: 10.1007/s002460010202.
17) Robinson BV, Brzezinska-Rajszys G, Weber HS, Ksiazyk
J, Fricker FJ, Fischer DR, et al. Balloon aortic valvotomy
through a carotid cutdown in infants with severe aortic
stenosis: Results of the multi-centric registry. Cardiol Young
2000;10:225-32. doi: 10.1017/s104795110000915x.
18) Peek GJ, Firmin RK, Moore HM, Sosnowski AW.
Cannulation of neonates for venovenous extracorporeal life
support. Ann Thorac Surg 1996;61:1851-2. doi: 10.1016/0003-
4975(96)00173-7.
19) Sen O, Aydin U, Kadirogullari E, Bayram M, Karacalilar M,
Kutluk E, et al. Mid-term results of peripheral cannulation
after robotic cardiac surgery. Braz J Cardiovasc Surg
2018;33:443-7. doi: 10.21470/1678-9741-2018-0061.
20) Marone EM, Brioschi C, Pallini M, Marazzi G, Chierico S,
Rinaldi LF. Mini-surgical access prevents local complications
and reduces costs in endovascular aortic repair. Ann Vasc
Surg 2022;86:111-6. doi: 10.1016/j.avsg.2022.05.014.
21) Nelson PR, Kracjer Z, Kansal N, Rao V, Bianchi C, Hashemi
H, et al. A multicenter, randomized, controlled trial of
totally percutaneous access versus open femoral exposure
for endovascular aortic aneurysm repair (the PEVAR trial). J
Vasc Surg 2014;59:1181-93. doi: 10.1016/j.jvs.2013.10.101.
22) Cakici M, Yazicioglu L, Baran C, Ozcinar E, Ozgur A,
Soykan C, et al. A retrospective analysis of surgical femoral
artery closure techniques: Conventional versus purse suture
technique. Ann Vasc Surg 2017;44:103-12. doi: 10.1016/j.
avsg.2017.04.032.
23) Lahiri S, Qureshi AM, Justino H, Mossad EB. Percutaneous
common carotid artery access for cardiac interventions in
infants does not acutely change cerebral perfusion. Pediatr
Cardiol 2022;43:104-9. doi: 10.1007/s00246-021-02697-9.